Pathstone Family Office’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $15.2M | Buy |
|
|||||
|
2023
Q2 | $7.21M | Buy |
|
|||||
|
2023
Q1 | $8.04M | Sell |
|
|||||
|
2022
Q4 | $24.2M | Buy |
|
|||||
|
2022
Q3 | $18.8M | Buy |
|
|||||
|
2022
Q2 | $4.16M | Buy |
|
|||||
|
2022
Q1 | $2.76M | Buy |
|
|||||
|
2021
Q4 | $2.21M | Buy |
|
|||||
|
2021
Q3 | $1.47M | Buy |
|
|||||
|
2021
Q2 | $1.06M | Buy |
|
|||||
|
2021
Q1 | $725K | Buy |
|
|||||
|
2020
Q4 | $703K | Buy |
|
|||||
|
2020
Q3 | $139K | Buy |
|
|||||
|
2020
Q2 | $100K | Sell |
|
|||||
|
2020
Q1 | $131K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $18K | Sell |
|
|||||
|
2019
Q2 | $573K | Sell |
|
|||||
|
2019
Q1 | $570K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $19K | Sell |
|
|||||
|
2017
Q4 | $28K | Sell |
|
|||||
|
2017
Q3 | $29K | Sell |
|
|||||
|
2017
Q2 | $304K | Sell |
|
|||||
|
2017
Q1 | $328K | Sell |
|
|||||
|
2016
Q4 | $405K | Buy |
|
|||||
|
2016
Q3 | $76K | Sell |
|
|||||
|
2016
Q2 | $101K | Buy |
|
|||||
|
2016
Q1 | $86K | Buy |
|
|||||
|
2015
Q4 | $4K | Sell |
|
|||||
|
2015
Q3 | $6K | Buy |
|
|||||
|
2015
Q2 | $4K | Buy |
|
|||||
|
2015
Q1 | $4K | Buy |
|
|||||
|
2014
Q4 | $3K | Sell |
|
|||||
|
2014
Q3 | $29K | Buy |
|
|||||
|
2014
Q2 | $3K | Buy |
|
|||||
|
2014
Q1 | $3K | Buy |
|
|||||
|
2013
Q4 | $3K | Sell |
|
|||||
|
2013
Q3 | $127K | Sell |
|
|||||
|
2013
Q2 | $152K | Buy |
|